PPT-In Care: Viral Load Suppression

Interventions 1 Form a QI team to specifically address VLS 2 Utilize CAREWare to identify nonsuppressed patients 3 Team creates a Fishbone diagram to identify barriers to viral load suppression. Point-of-Care . Virologic. Testing for HIV/AIDS . Scaling up . Virologic. Diagnostic HIV Testing in Infants and Rationalizing Decentralization of Testing Through the Use of Point-of-Care Technologies . Evidence from modelling and economic analysis. Operationalising 90:90:90 from inputs to outputs. Rainbow Towers Conference Centre, Harare, Zimbabwe. 2 December 2015. Andrew Phillips, . Paul Revill. , Tim . Council of State and Territorial Epidemiologists Annual Conference. June 4, 2012. Omaha, Nebraska. Tom Jaenicke, MPH, MBA, MES. Washington State Department of Health. Tom.Jaenicke@doh.wa.gov. Outline for today. May 21, . 2013. . For Audio: Dial-in#: 866.394.2346 Participant Code: 397 154 6368#. Welcome & . Overview, . 5 . mins. Maximizing Virologic Suppression, . 35 . mins. Panel Discussion . Associate Administrator. HIV/AIDS Bureau (HAB). Health Resources and Services Administration (HRSA). Ryan White HIV/AIDS Program Update. San Antonio, Texas: August 21-23, 2017. Secretary Price’s . Principles and Priorities. reducing Viral transmission –VL monitoring in ART cohorts. 19/11/15. AWACC. Towards the 90/90/90 goals of the National programme for HIV/TB services. DOH-CAPRISA –UKZN- NHLS PROJECT. Dr.. Henry Sunpath. Making Viral Load Routine Implementation experience from MSF Dr Helen Bygrave IAC 2016 Programmatic and Laboratory Must Speak to Each Other www.msfaccess.org/makingviralloadroutine Sites for Routine VL monitoring Nicholas Van Sickels, MD; Jason Halperin, MD, MPH; Isolde Butler, MD, MPH; Katherine Conner, MPH; Josh Fegley, LCSW-BACS; Fran Lawless; Pam Holm, Joseph Olsen, MPH. CrescentCare. , New Orleans. Objectives. John T. Brooks, MD . Senior Medical Advisor, CDC Division of HIV/AIDS Prevention. Dr. Brooks has no relevant financial affiliations to disclose. Sexual Transmission Reduced with Lower Blood Viral Load. Adherence. Counseling. Flipchart. Adults, non-pregnant. nor breastfeeding. The mark “CDC” is owned by the US Dept. of Health and Human Services and is used with permission. Use of this logo is not an endorsement by HHS or CDC of any particular product, service, or enterprise.. and. HIV Resistance Assays. www.hivguidelines.org. JUNE 2023. NYSDOH AIDS Institute Clinical Guidelines Program. Purpose of These Guidelines. Virologic and Immunologic Monitoring in HIV Care. Guide clinicians in the use of HIV viral load testing at appropriate times and intervals to assess initial and ongoing ART responses. Study Aim. The aim of the study was to evaluate the effect of high VL guardian sessions towards VL re-suppression among children aged 0-5 years enrolled in DSD care at Tisungane clinic in Zomba, Malawi. . Mexico City, Mexico. July 2019. Title. Kenya. Zimbabwe. Uganda. Note: this slide only reflects the PCR testing labs used for VL testing in the public sector. This excludes private PCR testing labs or those used for research purposes. Some circle represent multiple labs in the same city. Learning Objectives. Understand the dynamics of viral load during the course of HIV infection. Understand how viral load affects risk for transmission and progression of HIV. Explain how viral load responds to antiretroviral therapy (ART).